Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies.

CONCLUSIONS: Regardless of patient predicted risk of post-PE complications, real-world studies suggest rivaroxaban is associated with a reduced hospital LOS and costs versus parenterally-bridged warfarin, without increasing readmission. PMID: 28665208 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research